Tired of the limitations of traditional benzene rings in drug design? Bicyclo[2.2.2]octane (BCO), a saturated 3D bridged bicyclic scaffold, is here to change the game as a top-tier benzene bioisostere in medicinal chemistry. Its rigid, sp³-rich structure builds a compact, stable cage-like framework that’s perfectly built for modern drug development.

Wondering what makes BCO stand out? This stable scaffold brings unbeatable perks to drug discovery: it sharply boosts metabolic stability by avoiding aromatic oxidation, and fine-tunes lipophilicity and water solubility to greatly improve druggability.

Even better, its rigid shape binds to drug targets with barely any conformational shifts — this means stronger binding affinity, better selectivity, and fewer off-target side effects. It’s easy to see why BCO is the go-to choice for optimizing ADME profiles and lead compound performance.

Explore our portfolio: www.arctomsci.com/store/chemscene

Product Inquiry: [email protected]